Tardive dyskinesia associated with metoclopramide in persons with developmental disabilities

Research in Developmental Disabilities

Volumn 23, Issue 3, 2002, Pages 224-233

  Matson, Johnny L ^a   Mayville, Erik A ^a   Bielecki, JoAnne ^a   Smalls, Yemonja ^a   Eckholdt, C Scott ^b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Pinecrest Developmental Center   (United States)

Author keywords

Mental retardation; Metoclopramide; Tardive dyskinesia

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; METOCLOPRAMIDE; NEUROLEPTIC AGENT; THIORIDAZINE; ANTIEMETIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; RELIABILITY; STANDARDIZATION; TARDIVE DYSKINESIA; VALIDATION PROCESS; COMORBIDITY; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; DYSKINESIA; MENTAL DISEASE; MIDDLE AGED; NEUROLOGIC EXAMINATION; RISK FACTOR;

ADULT; ANTIEMETICS; ANTIPSYCHOTIC AGENTS; COMORBIDITY; COMPARATIVE STUDY; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMAN; MALE; MENTAL DISORDERS; MENTAL RETARDATION; METOCLOPRAMIDE; MIDDLE AGE; NEUROLOGIC EXAMINATION; RISK FACTORS; HUMANS; MIDDLE AGED;

EID: 0036001329     PISSN: 08914222     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-4222(02)00100-2     Document Type: Article

References (18)

1. Drugs and the treatment of psychiatric disorders: Psychosis and anxiety
2. Tardive dyskinesia in the mentally retarded: Comparison of prevalence, risk factors and topography with a schizophrenic population
3. Adverse neuropsychiatric effects of dopamine antagonist medications: Misdiagnosis in the medical setting
4. Comparison of severe and mild tardive dyskinesia: Implications for etiology
5. Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting
6. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders
7. Adverse neurologic effects of metoclopromide
8. Tardive dyskinesia
9. Tardive dyskinesia and developmental disabilities: An examination of demographics and topography in persons with dual diagnosis
10. Metoclopramide-induced movement disorders: Clinical findings with a review of the literature
11. The prevalence of tardive dyskinesia in a mentally retarded population
12. Metoclopramide-associated tardive dyskinesia: An analysis of 67 cases
13. Metoclopramide and tardive dyskinesia
14. Reliability and a total score cutoff for the Dyskinesia Identification System: Condensed User Scale (DISCUS) with mentally ill and mentally retarded populations
15. Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: Relationship of developmental intellectual deficit and presence or absence of long-term exposure to neuroleptics
16. Tardive dyskinesia associated with metoclopramide
17. Side effects: Recognition and management